Pancreatic Cancer Research

ResearcherThe Ohio State UniversityActive in the last 2 years

Lianbo Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2025-2585; OpenAlex author ID A5048499133. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 7

  1. Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights. Co-author DOI 10.3389/fonc.2025.1544928↗
  2. Serum MUC5AC Predicts Recurrence in Pancreatic Ductal Adenocarcinoma Patients on Neoadjuvant Chemotherapy Co-author DOI 10.20944/preprints202409.0945.v1↗
  3. Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes. Last author DOI 10.3390/ijms25169041↗
  4. Differential Expression and Diagnostic Value of MUC5AC Glycoforms in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers15194832↗
  5. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2016-311585↗
  6. Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele. Co-author DOI 10.1371/journal.pone.0184984↗
  7. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-013-3240-y↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ashwini Kumar Esnakula · 4 shared papers, 2023–2025 · strength 0.75
  2. Ashish Manne · 4 shared papers, 2023–2025 · strength 0.75
  3. Upender Manne Manne · 3 shared papers, 2024–2025 · strength 0.51
  4. Kannan Thanikachalam · 3 shared papers, 2024–2025 · strength 0.51
  5. Wancai Yang · 3 shared papers, 2024–2025 · strength 0.51
  6. Ankur Sheel · 3 shared papers, 2024–2025 · strength 0.51
  7. Jordan M. Cloyd · 3 shared papers, 2024–2025 · strength 0.51
  8. Anup Kasi · 3 shared papers, 2024–2025 · strength 0.51
  9. Ravi Kumar Paluri · 3 shared papers, 2024–2025 · strength 0.51
  10. Deepak Sherpally · 2 shared papers, 2024–2025 · strength 0.36
  11. Sameek Roychowdhury · 2 shared papers, 2024 · strength 0.31
  12. Mary E. Dillhoff · 2 shared papers, 2024 · strength 0.31
  13. Anne M. Noonan · 2 shared papers, 2024 · strength 0.31
  14. Aslam M. Ejaz · 2 shared papers, 2024 · strength 0.31
  15. Shafia Rahman · 2 shared papers, 2024 · strength 0.31
  16. Allan Tsung · 1 shared paper, 2023 · strength 0.24
  17. Phil A. Hart · 1 shared paper, 2023 · strength 0.24
  18. Timothy Michael Pawlik · 1 shared paper, 2025 · strength 0.21
  19. Davendra P. S. Sohal · 1 shared paper, 2024 · strength 0.15
  20. Eric David Miller · 1 shared paper, 2024 · strength 0.15
  21. Kenneth L Pitter · 1 shared paper, 2024 · strength 0.15
  22. Jason Robert Pitarresi · 2 shared papers, 2017–2018 · strength 0.13
  23. Michael C. Ostrowski · 2 shared papers, 2017–2018 · strength 0.13
  24. Mark Bloomston · 2 shared papers, 2014–2018 · strength 0.11
  25. Xiaoling Zhong · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.